Comparison of prognosis between neoadjuvant imatinib and upfront surgery for GIST: A systematic review and meta-analysis

Background: Significant survival benefit of adjuvant imatinib therapy has been observed in gastrointestinal stromal tumor (GIST). However, the impact of neoadjuvant imatinib on prognosis of GIST remains unclear. This meta-analysis aimed to compare the prognostic impact between upfront surgery and ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zhen, Zhang, Zimu, Sun, Juan, Li, Jie, Zeng, Ziyang, Ma, Mingwei, Ye, Xin, Feng, Fan, Kang, Weiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465640/
https://www.ncbi.nlm.nih.gov/pubmed/36105195
http://dx.doi.org/10.3389/fphar.2022.966486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465640/
https://www.ncbi.nlm.nih.gov/pubmed/36105195
http://dx.doi.org/10.3389/fphar.2022.966486

Ejemplares similares